Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

Empower Clinics Provides Corporate Update
VANCOUVER, BC / ACCESSWIRE / August 18, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated healthcare company with a developing research and clinical trials division announces various corporate updates. CEASE TRADE ORDER On August 15th, 2023 the British Columbia Securities Commission ("BCSC") issued a bulletin announcing Empower is suspended pursuant to CSE Policy 3.» Mehr auf accesswire.com
Empower Clinics Announces Closing of Second Tranche Private Placement Financing
VANCOUVER, BC / ACCESSWIRE / August 15, 2023 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:EPW)(OTC PINK:EPWCF), is pleased to announce that it has closed a second tranche private placement of units of the Company (the "Units"), pursuant to which the Company issued 1,625,000 Units at a price of $0.04 per Unit (the "Offering Price") for aggregate gross proceeds of $65,000 (the "Offering"). Each Unit is comprised of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"), with each Warrant exercisable to acquire one Common Share (a "Warrant Share") at a price of $0.05 per Warrant Share for a period of 24 months from the closing of the Offering.» Mehr auf accesswire.com
Empower Clinics Announces Closing of First Tranche Private Placement Financing
VANCOUVER, BC / ACCESSWIRE / August 9, 2023 / Empower Clinics Inc. ("Empower" or the "Company") (CSE:EPW)(OTC PINK:EPWCF), is pleased to announce that it has closed a first tranche private placement of units of the Company (the "Units"), pursuant to which the Company issued 6,016,250 Units at a price of $0.04 per Unit (the "Offering Price") for aggregate gross proceeds of $240,250 (the "Offering"). Each Unit is comprised of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"), with each Warrant exercisable to acquire one Common Share (a "Warrant Share") at a price of $0.05 per Warrant Share for a period of 24 months from the closing of the Offering.» Mehr auf accesswire.com

Unternehmenszahlen

Im letzten Jahr hatte Empower Clinics einen Umsatz von 4,35 Mio€ und ein Nettoeinkommen von −2,63k€

(EUR)	2022	YOY
Umsatz	+4,35 Mio	13,12%
Bruttoeinkommen	+1,83 Mio	54,65%
Nettoeinkommen	−2,63k	99,99%
EBITDA	−1,01 Mio	96,25%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+2,15 Mio€
Anzahl Aktien	25,36 Mrd
52 Wochen-Hoch/Tief	+0,0000849€ - +8e-7€
Dividenden	Nein
Beta	2,06
KGV (PE Ratio)	−2,48
KGWV (PEG Ratio)	−0,02
KBV (PB Ratio)	0,00
KUV (PS Ratio)	+0,54

Unternehmensprofil

Empower Clinics Inc. ist ein integriertes Gesundheitsunternehmen, das durch digitale und telemedizinische Betreuung und medizinische Diagnoselabore in den Vereinigten Staaten und Kanada Wellness-Dienstleistungen für Körper und Geist anbietet. Das Unternehmen betreibt eine Pipeline von 33 Kliniken in Alberta, British Columbia und New Brunswick. Es ist eine strategische Allianz mit SoLVBL Solutions Inc. eingegangen, um ein Programm für die Datensicherheit bei diagnostischen Tests zu entwickeln. Empower Clinics Inc. hat seinen Sitz in Vancouver, Kanada.